Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Clin Exp Immunol ; 124(1): 134-41, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11359452

RESUMEN

CIA in the rhesus monkey is an autoimmune-based polyarthritis with inflammation and erosion of synovial joints that shares various features with human rheumatoid arthritis (RA). The close phylogenetic relationship between man and rhesus monkey makes the model very suitable for preclinical safety and efficacy testing of new therapeutics with exclusive reactivity in primates. In this study we have investigated the prophylactic and therapeutic effects of a humanized monoclonal antibody (Daclizumab) against the alpha-chain of the IL-2 receptor (CD25). When Daclizumab treatment was started well after immunization but before the expected onset of CIA a significant reduction of joint-inflammation and joint-erosion was observed. A therapeutic treatment, initiated as soon as the first clinical signs of CIA were observed, proved also effective since joint-degradation was abrogated. The results of this study indicate that Daclizumab has clinical potential for the treatment of RA during periods of active inflammation and suppression of the destruction of the joint tissues.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Artritis Reumatoide/tratamiento farmacológico , Enfermedades Autoinmunes/tratamiento farmacológico , Inmunoglobulina G/uso terapéutico , Receptores de Interleucina-2/antagonistas & inhibidores , Animales , Anticuerpos Monoclonales Humanizados , Especificidad de Anticuerpos , Artritis Reumatoide/inducido químicamente , Artritis Reumatoide/patología , Artritis Reumatoide/prevención & control , Autoanticuerpos/sangre , Autoanticuerpos/inmunología , Enfermedades Autoinmunes/inducido químicamente , Enfermedades Autoinmunes/patología , Enfermedades Autoinmunes/prevención & control , Proteína C-Reactiva/análisis , Colágeno/inmunología , Colágeno/toxicidad , Daclizumab , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Humanos , Hidroxiprolina/orina , Inmunización , Macaca mulatta , Masculino , Receptores de Interleucina-2/inmunología , Pérdida de Peso
2.
Lab Anim ; 24(4): 375-9, 1990 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-2148606

RESUMEN

To obtain a suitable species-specific microflora for a new rat SPF-unit, germ-free WAG/Rij rats were associated with a flora derived originally from selectively decontaminated Cpb: WU (Wistar) rats. Caecal and ileal contents of these rats had been cultured anaerobically (37 degrees C) for 7 days and harvested. This cultured flora was given to germ-free Cpb: SE (Swiss) mice, which were kept in an isolator system and acted as a source of the flora to associate germ-free Wag/Rij rats. In these associated rats, several parameters indicative of the 'quality' of the intestinal microflora were investigated and compared to those in rats with a mouse derived anaerobic microflora. Parameters included relative caecal weight, colonization resistance and the concentration of faecal bile acids. The cultured rat-derived microflora normalized the observed intestinal parameters better than the mouse derived microflora, and provided better colonization resistance. We conclude that culturing of intestinal contents of selectively decontaminated animals can be a useful way to obtain a species-specific donor-microflora which can be used to start new SPF units.


Asunto(s)
Intestinos/microbiología , Organismos Libres de Patógenos Específicos , Animales , Bacterias/aislamiento & purificación , Ciego/microbiología , Vida Libre de Gérmenes , Íleon/microbiología , Ratones , Ratas , Especificidad de la Especie
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...